Project Grant R01GM166347
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a $390,966 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, through March 31, 2031. The grant funds fundamental research investigating the roles of the epitranscriptome—the comprehensive collection of ribonucleic acid (RNA) modifications—in optimizing gene expression across...
- Federal Project Grant Award Summary Cornell University's Office of Sponsored Programs received a $423,195 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, through January 31, 2031. The award funds basic research investigating the molecular and genetic mechanisms underlying gene-by-environment (GxE) interactions—specifically, how organisms' phenotypes are shaped...
- Federal Project Grant Award Summary Cornell University received a $380,785 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 15, 2025, with completion targeted for August 31, 2030. The award supports research on quantitative recovery of biomolecular structural ensembles from cryo-electron microscopy (cryo-EM), a technique that captures protein conformational states by...
- Federal Project Grant Award Summary Cornell University was awarded $380,262 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop theoretical and computational methods for investigating redox processes in biological systems. The project, initiated August 1, 2025, and concluding July 31, 2030, will deliver a simulation toolbox utilizing path integral quantum mechanics formulations to characterize electron...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $299,673 under the Biomedical Research and Research Training program (CFDA 93.859) to The Research Foundation for the State University of New York, operating through the University at Albany, for the project "Investigating Regulatory Mechanisms of In Vivo Transcriptional Dynamics." The award, effective April 1, 2026, with completion targeted for December 31, 2030, supports fundamental...
- Federal Grant Award Summary Cornell University received a $431,750 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with a completion date of February 28, 2031. This award supports basic research investigating the drivers of convergent molecular evolution during adaptation, with a specific focus on how insects have independently evolved resistance to cardenolides—plant...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Research Foundation for the State University of New York a $2.2 million Project Grant on September 20, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to support fundamental research on transcription factor binding to chromatin. The research project, which runs through August 31, 2029, will systematically investigate the mechanistic rules governing how...
- Federal Project Grant Award Summary Cornell University's Office of Sponsored Programs received a $404,864 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 22, 2026, with completion targeted for March 31, 2031. The award supports fundamental research into quantitative membrane contact site biology in autophagy, an intracellular degradation process essential for cellular...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a $258,713 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026 through June 30, 2031. The award supports investigator-initiated basic research to advance understanding of phospholipid homeostasis in eukaryotic cells. The research project, conducted at Cornell's Ithaca, NY campus,...
- Federal Project Grant Award Summary Cornell University's Office of Sponsored Programs received a $291,491 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with a completion date of January 31, 2031. The award supports fundamental research aimed at understanding autolysin function in gram-negative bacterial growth and morphogenesis. The project investigates how...
Cornell University's Office of Sponsored Programs received a $482,612 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026, through April 30, 2030. The award supports fundamental research to decipher regulatory syntax governing gene transcription by analyzing computational models that predict how DNA sequence motifs encoding transcription factor binding sites control transcriptional activity. The project develops advanced interpretation tools to uncover syntax rules that govern interactions between transcriptional activators, repressors, and DNA sequence elements that direct preinitiation complex (PIC) assembly, RNA polymerase II (Pol II) pausing, and nucleosome positioning—specifically addressing how steric constraints determine the correct positioning and orientation of transcription factors relative to Pol II and nucleosome complexes. The research builds on the investigators' development of CLIPNET, a machine learning model that identifies intricate motif syntax relationships and accurately explains how DNA sequence governs transcription initiation at human cis-regulatory elements. Primary deliverables include comprehensive analysis of computational models to identify generalizable regulatory syntax rules, determination of whether syntax constraints are conserved among transcription factors with similar activation domains, and empirical validation of the computational predictions through advanced interpretation methodologies. The work addresses a fundamental gap in understanding gene regulation, as few generalizable rules have emerged regarding regulatory syntax despite prior research focusing on transcriptional activator interactions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $482.6k | 6/25/26 |